Literature DB >> 1512461

Cytoplasmic domain of the 180-kD bullous pemphigoid antigen, a hemidesmosomal component: molecular and cell biologic characterization.

S B Hopkinson1, K S Riddelle, J C Jones.   

Abstract

Using a serum sample of a bullous pemphigoid (BP) patient we have isolated a cDNA clone encoding a portion of a 180-kD polypeptide component of the hemidesmosome, the "BP180 autoantigen." The identity of the clone was confirmed by the generation of a fusion protein antibody that recognizes BP180 in both a basal epithelial cell extract of bovine tongue and extracts of human epidermal cells. Immunoelectron microscopy indicates that the 588-bp cDNA encodes a cytoplasmic fragment of BP180. Furthermore, the wide species reactivity of the fusion protein suggests that this portion of BP180 is highly conserved. In cultured human epidermal cells processed for confocal immunofluorescence microscopy, the fusion protein antibody generates a punctate cell substrate-associated staining pattern that is similar to that seen using BP230 antibodies. Using the original BP180 cDNA we have now isolated additional cDNA clones encoding approximately 1800bp of BP180 the 3' sequence of which overlaps with the sequence detailed in Guidice et al (J Clin Invest 87:734-738, 1991). Secondary structural analyses have been undertaken on the predicted amino acids encoded by the 1800bp. These suggest that the collagen-like sequences of BP180 described by Guidice et al (ibid.) are separated by a putative transmembrane region from the domain of BP180 recognized by our fusion protein antibody. Indeed, BP180 appears to belong to a relatively rare group of proteins in which the N-terminus is located in the cytoplasm and the C-terminus is extracellular. We detail some preliminary biochemical experiments in support of this hypothesis. We discuss possible functions of BP180 and BP230 in the hemidesmosome.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1512461     DOI: 10.1111/1523-1747.ep12616615

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  34 in total

1.  The N terminus of the transmembrane protein BP180 interacts with the N-terminal domain of BP230, thereby mediating keratin cytoskeleton anchorage to the cell surface at the site of the hemidesmosome.

Authors:  S B Hopkinson; J C Jones
Journal:  Mol Biol Cell       Date:  2000-01       Impact factor: 4.138

2.  α6β4 integrin, a master regulator of expression of integrins in human keratinocytes.

Authors:  Kristina R Kligys; Yvonne Wu; Susan B Hopkinson; Surinder Kaur; Leonidas C Platanias; Jonathan C R Jones
Journal:  J Biol Chem       Date:  2012-04-06       Impact factor: 5.157

3.  Caspase proteolysis of the integrin beta4 subunit disrupts hemidesmosome assembly, promotes apoptosis, and inhibits cell migration.

Authors:  Michael E Werner; Feng Chen; Jose V Moyano; Fruma Yehiely; Jonathan C R Jones; Vincent L Cryns
Journal:  J Biol Chem       Date:  2006-12-18       Impact factor: 5.157

4.  BPAG1e maintains keratinocyte polarity through beta4 integrin-mediated modulation of Rac1 and cofilin activities.

Authors:  Kevin J Hamill; Susan B Hopkinson; Philip DeBiase; Jonathan C R Jones
Journal:  Mol Biol Cell       Date:  2009-04-29       Impact factor: 4.138

Review 5.  Complement and cutaneous autoimmune blistering diseases.

Authors:  Elizabeth Lessey; Ning Li; Luis Diaz; Zhi Liu
Journal:  Immunol Res       Date:  2008       Impact factor: 2.829

6.  Dual targets for mouse mast cell protease-4 in mediating tissue damage in experimental bullous pemphigoid.

Authors:  Lan Lin; Eric Bankaitis; Lisa Heimbach; Ning Li; Magnus Abrink; Gunnar Pejler; Lijia An; Luis A Diaz; Zena Werb; Zhi Liu
Journal:  J Biol Chem       Date:  2011-08-31       Impact factor: 5.157

7.  Human autoantibodies against the 230-kD bullous pemphigoid antigen (BPAG1) bind only to the intracellular domain of the hemidesmosome, whereas those against the 180-kD bullous pemphigoid antigen (BPAG2) bind along the plasma membrane of the hemidesmosome in normal human and swine skin.

Authors:  A Ishiko; H Shimizu; A Kikuchi; T Ebihara; T Hashimoto; T Nishikawa
Journal:  J Clin Invest       Date:  1993-04       Impact factor: 14.808

8.  92-kD gelatinase is produced by eosinophils at the site of blister formation in bullous pemphigoid and cleaves the extracellular domain of recombinant 180-kD bullous pemphigoid autoantigen.

Authors:  M Ståhle-Bäckdahl; M Inoue; G J Guidice; W C Parks
Journal:  J Clin Invest       Date:  1994-05       Impact factor: 14.808

9.  The role of complement in experimental bullous pemphigoid.

Authors:  Z Liu; G J Giudice; S J Swartz; J A Fairley; G O Till; J L Troy; L A Diaz
Journal:  J Clin Invest       Date:  1995-04       Impact factor: 14.808

10.  Absence of human herpesvirus 8 in pemphigus and bullous pemphigoid.

Authors:  Anjela Galan; Pei Hui; Jennifer M McNiff
Journal:  Int J Clin Exp Pathol       Date:  2009-01-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.